Navigation Links
Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
Date:1/7/2008

PALO ALTO, Calif., Jan. 7 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) announced that company management will provide a corporate overview at the 26th Annual JPMorgan Healthcare Conference in San Francisco, CA on Thursday, January 10, 2008 at 7:30 a.m. Pacific time (10:30 a.m. Eastern time). A live and archived webcast of the presentation will be available on the Telik website, http://www.telik.com.

Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced drug development candidates are TELCYTA(R), a tumor-activated small molecule product candidate in clinical development for the treatment of advanced ovarian cancer and non-small cell lung cancer; and TELINTRA(TM), which is in clinical development for the treatment of myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(TM), which enables the rapid and efficient discovery of small molecule drug candidates.


'/>"/>
SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
2. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
3. NxStage Medical Announces Needle Supply Agreement with DaVita
4. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
5. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
6. Burrill & Company Announces Promotions
7. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
9. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
10. Exelixis Announces Senior Management Promotions
11. Genmab Announces HuMax-CD32b Pre-Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Personal Genome Diagnostics ... its proprietary methodologies and expertise in genomic analysis ... targets in collaboration with Blueprint Medicines.  PGDx is ... identifying genomic alterations in tumors, and Blueprint Medicines ... inhibitors for a genetically defined patient population. ...
(Date:5/21/2013)... MN (PRWEB) May 21, 2013 Revolutionary ... patented automatic colony counter, announced today that they have ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... and sophistication are especially useful in food microbiology and ... given an updated look. A bright white enclosure ...
(Date:5/21/2013)... Ontario (PRWEB) May 21, 2013 ... scientists of the ITN to design the study, ... of two key clinical models used in the ... (EEC) and Nasal Allergen Challenge (NAC) models. Although ... by numerous publications, to date no direct comparison ...
(Date:5/21/2013)... 2013 Possible mold re-infestation in Guilemtte School ... a report from eagletribune.com posted May 14, 2013, the state ... result is positive, My Cleaning Products offered a tip ... , It was said in the Eagle Tribune report (5.14.13) ... campus sparked after a first-grade classroom was closed due to ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
... Ill., May 3, 2011 Landauer, Inc. (NYSE: ... and environmental radiation monitoring and the leading domestic provider of ... fiscal 2011 second quarter ended March 31, 2011.   ... grew 2 percent to $32.3 million on contribution from Medical ...
... Answering the need for global, site-focused enrollment support, ... enrollment industry, announces the expansion of its services to ... site-centric level. "The extension of our worldwide ... to assist sponsors with their global patient enrollment needs," ...
... Corporation (NASDAQ: TECH ) (Techne) announced today ... Limited and subsidiaries (Tocris), a leading supplier of reagents ... in both in-vitro and in-vivo experiments, to understand biological ... biologically active neuro- and bio-chemicals which are used by ...
Cached Biology Technology:Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 2Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 3Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 4Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 5Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 6Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 7Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 8Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 9Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 10Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 11Landauer, Inc. Reports Fiscal 2011 Second Quarter Results 12Clinical Site Services Expands to Provide Global Patient Enrollment Services to Rest-of-World 2Techne Corporation Announces Acquisition 2Techne Corporation Announces Acquisition 3Techne Corporation Announces Acquisition 4Techne Corporation Announces Acquisition 5
(Date:5/20/2013)... of Minnesota Medical School researchers from the Masonic Cancer ... Brain Tumor Program, have developed a new mouse model ... them to discover new genes and gene pathways driving ... this week in the journal Nature Genetics . ... the lab of David Largaespada, Ph.D., professor in the ...
(Date:5/20/2013)... COLUMBUS, Ohio New research suggests that a compound ... "superpower" to escape death. , By altering a ... re-educates cancer cells into normal cells that die as ... by inhibiting a process that would cause them to ... strict programming. This study in cells, led by Ohio ...
(Date:5/20/2013)... conducted at the University of Bristol and published online ... sheds light on how the brain and inner ear ... School of Earth Sciences, together with Tom Hbner from ... of 150 million year old dinosaurs. , The two ... Dysalotosaurus lettowvorbecki : a very young (juvenile) individual ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3Fossil brain teaser 2
... invites you to attend its first workshop on male ... clinical practice". The workshop provides a forum ... discuss new developments. Here some of the ... outside of Europe will announce: Nature ...
... ,The American Association of Pharmaceutical Scientists (AAPS) is ... employed in industry, academia, government and other research ... dynamic international forum for the exchange of knowledge ... health. AAPS offers timely scientific programs, on-going education, ...
... 2009 / b3c newswire / - PlatformQ , ... the healthcare, education and energy markets, and LabRoots ... scientific community, today announced the initial slate of speakers ... is the first of its kind online-only conference for ...
Cached Biology News:AAPS and PhRMA co-sponsor stability workshop 2BioConference Live Attracts Major Life Science Sponsors 2BioConference Live Attracts Major Life Science Sponsors 3